From: Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions
Trial | Mean time to site approval | Range of time to site approval |
---|---|---|
Trial 1 | 14Â months | Data not available |
Trial 4 | 4.8Â months | 0 to 8.4Â months |
Trial 5 | 20.7Â months | 16.8 to 24.9Â months |
Trial 6 | 7.9Â months | 3.9 to 12.9Â months |
Trial 7 | 5.5Â months | 3.2 to 12.6Â months |